-
Biocon Ltd receives approval from SAHPRA for Tacrolimus Capsule
21 Apr 2024 18:18 GMT
… our vertically integrated, complex drug product Tacrolimus capsule 0.5mg, 1mg and … .
Tacrolimus, a calcineurin inhibitor, is an immunosuppressant used in the treatment of …
-
Utilizing Guidelines to Navigate Patient Education, Comorbidities, and Treatment Options
19 Apr 2024 20:13 GMT
… key benchmarks, emerging trends, personalized medicine approaches, long-term safety considerations … of AD presentations, selecting appropriate treatment plans tailored to individual patient … for topical AD. And so, tacrolimus ointment is greasy. I don …
-
Lethal Immune Myocarditis and Myasthenia Gravis Due to Anti-PD-1 Treatment for a Bladder Cancer Patient: A Case Report and Possible Treatment Inspiration
18 Apr 2024 07:34 GMT
… year.3 Many clinical trials have evaluated the efficacy … an established role in modern medical institutions and may expand … the FDA-approved PD-1/PD-L1 antibody drugs for … or tacrolimus) improved the condition. Currently, there is no guiding treatment …
-
TFF Pharmaceuticals Announces Additional Positive Data from the Tacrolimus Inhalation Powder (TFF TAC) Phase 2 Trial Following Oral Presentation at the ISHLT 44th Annual Late Breaking Clinical Science Abstract Sessions
15 Apr 2024 11:00 GMT
… Professor Gregory Snell, Medical Head of Lung Transplant … of the trial is a 12-week treatment period, … Pharmaceuticals has two lead drug candidates in the clinic: TFF TAC (Tacrolimus … trials do not ensure later clinical trials will be successful; (iv) no drug …
-
TFF Pharmaceuticals Reports Addl. Positive Phase 2 Data For Tacrolimus Inhalation Powder
15 Apr 2024 11:47 GMT
… tacrolimus. Four out of 4 patients who completed the 12-week treatment … Pharmaceuticals said it plans to submit an Investigational New Drug … (IND) application to the FDA to … preparation for a registrational trial.
The results were …
-
Lipella Pharmaceuticals Announces FDA Type C Meeting for LP-10 for Hemorrhagic Cystitis
03 Apr 2024 12:00 GMT
… tacrolimus is a proprietary oral rinse formulation of Lipella’s lead drug … treatment of GvHD. About Lipella Pharmaceuticals Inc. Lipella Pharmaceuticals is a clinical-stage biotechnology …
-
Expert Insights: Unmet Needs in Topical Treatment for Atopic Dermatitis
12 Apr 2024 17:23 GMT
… quot; delves into nonsteroidal treatments for atopic dermatitis (AD). … nonsteroidal options such as tacrolimus and pimecrolimus were limited … options. Phase two trials demonstrated comparable efficacy to … difference early in clinical trials, given the advanced …
-
How One Woman ‘Dramatically Improved’ Her Debilitating Eczema Using Drugstore Creams
05 Apr 2024 16:13 GMT
… will try at-home remedies before consulting an expert. … dermatologist to help with treatment,” Dr. Garshick says. … tacrolimus and eucrisa, oral medications like JAK inhibitors, and injectable medications … the best treatment for her eczema took trial and error. …
-
With a rise in animal-human organ transplants, a drugmaker aims for a new standard of care
01 Apr 2024 12:00 GMT
… an experimental anti-rejection drug from Eledon Pharmaceuticals.
Dr. David-Alexandre Gros … bring tegoprubart through kidney transplant trials. The drug is also part of … the drug in a head-to-head phase 2 trial against tacrolimus, and …
-
Lipella Pharmaceuticals Announces FDA Clearance of IND for LP-410 for Oral Graft-Versus-Host Disease, Advancing Clinical Pipeline
05 Mar 2024 13:00 GMT
… Trial … treatment for this patient population.” Dr. Michael Chancellor, Lipella’s Chief Medical … FDA Orphan Drug Designation on tacrolimus for treatment … drug treatment of oral GVHD. About Lipella Pharmaceuticals
Lipella is a clinical-stage biotechnology …